No other potential conflict of interest relevant to this article was reported
By reducing risk factors and disease progression across several organ systems, GLP-1 therapies may add not just years to life, but life to years
These numbers are staggering because obesity is strongly associated with several conditions such as heart disease, stroke, type 2 diabetes, and cancer
Medium-size peptides are emerging as molecules bridging the gap between small molecules and biologics, showing potential to target previously challenging proteins to interact with using small molecules
Dosing errors have also been found with compounded tirzepatide, which many companies offer as an alternative to Mounjaro or Zepbound
Specifically, the energy intake per kilogram of weight appeared to be higher in the GHRP-2 group, measuring 136.013.0 kJ/kg compared to 101.310.5 kJ/kg in the control group